Press Resease

Plantar Fasciitis Treatment Market: by Type (Medication Therapy [Oral, and Parenteral], Orthotics, Shockwave Therapy [Extracorporeal Shock Wave Therapy, and Intracorporeal Pneumatic Shockwave Therapy], Surgery, and Others), and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Published Date: 29-Nov-2019 Category: Pharmaceutical Report Format : PDF Pages: 130 Report Code: ZMR-5116 Status : Published

Global demand for plantar fasciitis treatment market was valued at USD 603.3 million in 2018, and is expected to generate revenue of USD 2,469.1 million by end of 2025, growing at a CAGR of 22.3% between 2019 and 2025

Description

According to the report, global demand for plantar fasciitis treatment market was valued at USD 603.3 million in 2018, and is expected to generate revenue of USD 2,469.1 million by end of 2025, growing at a CAGR of 22.3% between 2019 and 2025

The report covers forecast and analysis for the global plantar fasciitis treatment market. The study provides historic data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Million). In-depth secondary research is used to ascertain overall market size, top industry players, top product, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports and other saws have also been considered to arrive at the indicated market numbers.

Plantar fasciitis is among the most common cause of injury related to the feet. It affects the heel portion of the foot and results into tenderness of the sole. It is a type of muscle sole inflammation and is highly prevalent among the people who stand on hard surfaces for long periods of time. This disease has emerged as a persistent repetitive strain injury which also afflicts hikers, runners, and walkers, and also those who stands for their living.

The study provides a decisive view on the plantar fasciitis treatment market by segmenting the market based on type, end user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The plantar fasciitis treatment market is segmented on the basis of type into medication therapy, orthotics, shockwave therapy, surgery, and others. The medication therapy market is further segmented into oral, and parenteral. The shockwave therapy market is further segmented into extracorporeal shock wave therapy, and intracorporeal pneumatic shockwave therapy. Shockwave therapy segment is likely to grow at high CAGR in the forecast period. Plantar fasciitis is gaining momentum due to common foot pain conditions which has also raised the number of treatments globally.

By end user the market is segmented into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment held major share of the market in terms of revenue in 2018 since medication therapy has gained traction due to most widely adopted line of therapy to manage symptoms related to plantar fasciitis like inflammation and pain. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries. Asia Pacific is likely to grow at high CAGR in the forecast period.

The study also includes drivers and restraints for the plantar fasciitis treatment along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the plantar fasciitis treatment market on global level. There has been wide range of treatments which are a promising ally combating severe pain caused due to plantar fasciitis, thus widening the scope of market growth for stakeholders. Large portion of the working class stands for sustained and longer time during their job and suffer from body pain, specifically foot and ankle pain which is among the predominant cause of plantar fasciitis and has also attributed to the fact that, that manufacturing sector continues to expand at an unprecedented rate of the global population engaged in this industry, who stands at one position for a long duration.

The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players in the market for plantar fasciitis treatment include A. Algeo Limited, Superfeet Worldwide, Inc., Hanger, Inc., Bayer Group (Dr. Scholl's), GlaxoSmithKline Plc, Bauerfeind AG, Pfizer, Inc., Sanofi, and Ottobock SE & Co., KGaA. (Ottobock Holding)

This report segments the global plantar fasciitis treatment market as follows:

Global Plantar Fasciitis Treatment Market: Type Segment Analysis

  • Medication Therapy
    • Oral
    • Parenteral
  • Orthotics
  • Shockwave Therapy
    • Extracorporeal Shock Wave Therapy (ESWT)
    • Intracorporeal Pneumatic Shockwave Therapy (IPST)
  • Surgery
  • Others

Global Plantar Fasciitis Treatment Market: End User Segment Analysis

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Global Plantar Fasciitis Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Plantar Fasciitis Treatment Market, 2016 - 2025, (USD Million)
    • 2.2. Plantar Fasciitis Treatment Market: Market Snapshot
  • Chapter 3. Global Plantar Fasciitis Treatment Market - Industry Analysis
    • 3.1. Plantar Fasciitis Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing availability of technically advanced product offerings and solutions for treatment of the disease
      • 3.2.2. Rising incidences of obesity
      • 3.2.3. Increasing prevalence and adoption of orthotics method of treatment prescribed by various healthcare facilities
      • 3.2.4. Unique & customized product designs for each individual designed to fit in a highly accurate nature
    • 3.3. Restraints
      • 3.3.1. Lack of stable raw materials pricing for the production of effective therapeutic medical devices
      • 3.3.2. Concerns regarding decline of profitability ratio for the products availability of large inventory and raw material stock with the manufacturers
    • 3.4. Opportunity
      • 3.4.1. Opportunities arising from developing countries
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by type segment
      • 3.6.2. Market attractiveness analysis by end user segment
      • 3.6.3. Market attractiveness analysis by regional segment
  • Chapter 4. Global Plantar Fasciitis Treatment Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global plantar fasciitis treatment market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Plantar Fasciitis Treatment Market - Type Segment Analysis
    • 5.1. Global plantar fasciitis treatment market overview: by type
      • 5.1.1. Global plantar fasciitis treatment market revenue share, by type, 2018 and 2025
    • 5.2. Medication Therapy
      • 5.2.1. Global plantar fasciitis treatment market by medication therapy, 2016 - 2025 (USD Million)
      • 5.2.2. Oral
        • 5.2.2.1. Global oral plantar fasciitis treatment market by medication therapy, 2016 - 2025 (USD Million)
      • 5.2.3. Parenteral
        • 5.2.3.1. Global parenteral plantar fasciitis treatment market by medication therapy, 2016 - 2025 (USD Million)
    • 5.3. Orthotics
      • 5.3.1. Global plantar fasciitis treatment market by orthotics, 2016 - 2025 (USD Million)
    • 5.4. Shockwave Therapy
      • 5.4.1. Global plantar fasciitis treatment market by shockwave therapy, 2016 - 2025 (USD Million)
      • 5.4.2. Extracorporeal Shock Wave Therapy
        • 5.4.2.1. Global extracorporeal shock wave therapy in plantar fasciitis treatment market by shockwave therapy, 2016 - 2025 (USD Million)
      • 5.4.3. Intracorporeal Pneumatic Shockwave Therapy
        • 5.4.3.1. Global intracorporeal pneumatic shockwave therapy in plantar fasciitis treatment market by shockwave therapy, 2016 - 2025 (USD Million)
    • 5.5. Surgery
      • 5.5.1. Global plantar fasciitis treatment market by surgery, 2016 - 2025 (USD Million)
    • 5.6. Others
      • 5.6.1. Global plantar fasciitis treatment market by others, 2016 - 2025 (USD Million)
  • Chapter 6. Global Plantar Fasciitis Treatment Market - End User Segment Analysis
    • 6.1. Global plantar fasciitis treatment market overview: by end user
      • 6.1.1. Global plantar fasciitis treatment market revenue share, by end user, 2018 and 2025
    • 6.2. Hospitals
      • 6.2.1. Global plantar fasciitis treatment market by hospitals, 2016 - 2025 (USD Million)
    • 6.3. Clinics
      • 6.3.1. Global plantar fasciitis treatment market by clinics, 2016 - 2025 (USD Million)
    • 6.4. Ambulatory Surgical Centers
      • 6.4.1. Global plantar fasciitis treatment market by ambulatory surgical centers, 2016 - 2025 (USD Million)
    • 6.5. Others
      • 6.5.1. Global plantar fasciitis treatment market by others, 2016 - 2025 (USD Million)
  • Chapter 7. Global Plantar Fasciitis Treatment Market - Regional Analysis
    • 7.1. Global plantar fasciitis treatment market overview: by region
      • 7.1.1. Global plantar fasciitis treatment market revenue share, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America plantar fasciitis treatment market, by country, 2016 - 2025 (USD Million)
      • 7.2.2. North America plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
      • 7.2.3. North America plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.2.4.2. The U.S. plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.2.5.2. Rest of North America plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe plantar fasciitis treatment market, by country, 2016 - 2025 (USD Million)
      • 7.3.2. Europe plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
      • 7.3.3. Europe plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.3.4. U.K.
        • 7.3.4.1. U.K. plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.3.4.2. U.K. plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.3.5. Germany
        • 7.3.5.1. Germany plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.3.5.2. Germany plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.3.6. France
        • 7.3.6.1. France plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.3.6.2. France plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.3.7.2. Rest of Europe plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific plantar fasciitis treatment market, by country, 2016 - 2025 (USD Million)
      • 7.4.2. Asia Pacific plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
      • 7.4.3. Asia Pacific plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.4.4.2. China plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.4.5.2. Japan plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.4.6.2. India plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America plantar fasciitis treatment market, by country, 2016 - 2025 (USD Million)
      • 7.5.2. Latin America plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
      • 7.5.3. Latin America plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.5.4.2. Brazil plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
        • 7.5.5.2. Rest of Latin America plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa plantar fasciitis treatment market, 2016 - 2025 (USD Million)
      • 7.6.2. Middle East & Africa plantar fasciitis treatment market revenue, by type, 2016 - 2025 (USD Million)
      • 7.6.3. Middle East & Africa plantar fasciitis treatment market revenue, by end user, 2016 - 2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. A. Algeo Limited
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Superfeet Worldwide, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Hanger, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Bayer Group (Dr. Scholl&s)
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. GlaxoSmithKline Plc
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. Pfizer, Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. Sanofi
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. Ottobock SE & Co., KGaA. (Ottobock Holding)
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. Bauerfeind AG
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Developments

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social